Search Results
(±)7-Hdohe inquiry | Purity Not Available
Alfa Chemistry
(±)7,8-DiHDoTrE 25 µg | ≥95%
Cayman Chemical
(±)7,8-DiHDoTrE 50 µg | ≥95%
Cayman Chemical
(±)7(8)-DiHDPA 1 mg | Purity Not Available
TargetMol
(±)7(8)-DiHDPA is a major metabolite of docosahexaenoic acid that is produced via oxidation by cytochrome P450 epoxygenases. Epoxygenase metabolites of DHA, including (±)7(8)-DiHDPA, suppress aggregation and thromboxane synthesis in isolated platelets.
More Information Supplier Page(±)7(8)-DiHDPA 1 mg | ≥98%
Cayman Chemical
(±)7(8)-DiHDPA 500 µg | ≥98%
Cayman Chemical
(±)7(8)-DiHDPA 100 µg | ≥98%
Cayman Chemical
(±)7(8)-DiHDPA 50 µg | ≥98%
Cayman Chemical
(±)7(8)-DiHDPA | MedChemExpress (MCE) 1 mg | ≥98.0%
MedChem Express
(±)7(8)-DiHDPA is a epoxygenase metabolite of docosahexaenoic acid (HY-B2167). (±)7(8)-DiHDPA inhibits platelet aggregation at concentrations below those affecting thromboxane synthesis[1].
More Information Supplier Page

